Puig Shares Fall on €1.2 Billion Debt-Financed ISDIN Buyout

Shares of Puig Brands (PUIGb) fell sharply after the company announced a €1.2 billion deal to acquire the remaining 50% stake in dermatology skincare brand ISDIN from its partner Esteve. The stock dropped 3.5% to €16.88 as investors weighed the immediate financial strain of the transaction against its long-term strategic benefits.

Investor Concerns Center on Debt

The market's negative reaction stems primarily from the deal's financing structure and its effect on Puig's balance sheet. According to the announcement, the acquisition will be funded through a combination of internal resources and new debt.

Key details of the transaction include:

• An initial payment of €900 million upon closing, which is expected by the end of the first quarter of 2027, pending regulatory approvals.
• A deferred payment of the remaining €300 million scheduled for the first quarter of 2029.

Ad

Analysts are concerned that the new debt will significantly increase the company's net leverage ratio. This move could compress Puig's financial flexibility at a time of uncertain consumer demand within the premium beauty sector.

Broader Market Headwinds

The sell-off in Puig shares was exacerbated by a weak broader market environment, with U.S. equity benchmarks also trading in negative territory. This global risk-off sentiment provided no support for the stock, amplifying the impact of the company-specific news.

The cautious mood also extends to the luxury beauty space, where investors are wary of large-scale M&A activity. The combination of the acquisition's scale, its reliance on debt, and a negative macroeconomic backdrop prompted the market to focus on the near-term costs of Puig's ambition to deepen its skincare footprint.